Survivorship of uncemented acetabular parts compared

Survivorship of uncemented acetabular parts compared
For total hip arthroplasty revisions, titanium wire mesh cups and cross-linked polyethylene liners are among new uncemented acetabular components that improve long-term implant survival, according to a study published in the June 20 issue of The Journal of Bone & Joint Surgery.

(HealthDay) -- For total hip arthroplasty revisions, titanium wire mesh cups and cross-linked polyethylene liners are among new uncemented acetabular components that improve long-term implant survival, according to a study published in the June 20 issue of The Journal of Bone & Joint Surgery.

To compare the survivorship of historical and current uncemented acetabular components following total hip arthroplasty, Hilal Maradit Kremers, M.D., of the Mayo Clinic in Rochester, Minn., and associates followed 3,236 patients who underwent 3,448 revision total hip arthroplasty procedures from 1984 through 2004. They compared overall and cause-specific survival rates of 10 different acetabular components, adjusting for age and sex.

The researchers identified 605 repeat revisions, including 386 cup revisions, with an overall survival rate of 69 percent at 15 years. Cup revision for aseptic loosening was significantly more common for beaded designs (hazard ratio [HR], 2.01) and less common for trabecular metal designs (HR, 0.25), compared with titanium wire mesh. During a median 5.2-year follow-up of 534 total arthroplasties with cross-linked polyethylene liners there were no liner revisions for wear and/or osteolysis. The risk of wear-related revision was significantly lower with cross-linked polyethylene than conventional liners. The risk of repeat revision was not associated with femoral head size or use of an elevated liner.

"In the setting of revision total , cup survival was worse with beaded acetabular designs compared with titanium wire mesh or highly porous designs," the authors write. "Cross-linked polyethylene liners were associated with a reduced risk of wear-related liner revision."

One or more of the authors disclosed receiving payments or services, either directly or indirectly, from a third party in support of an aspect of this work.

Abstract

Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Hormonal therapy for transsexualism safe and effective

13 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

16 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...